Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | Patent Application Number 16006493
16006493
Not Appealed
Patent NumberUS 10323092 B2
Publication NumberUS 20180282414 A1
Filled DateJun 12, 2018
Priority DateMay 15, 2012
Inventor/ApplicantsJon M. Wigginton
Xi-Tao Wang
Maria Jure-Kunkel
John P. COGSWELL
John P. Cogswell
Ashok K. Gupta
Stacie M. Goldberg
Xi-Tao Wang
Maria Jure-Kunkel
John P. COGSWELL
John P. Cogswell
Ashok K. Gupta
Stacie M. Goldberg
ExaminesOUSPENSKI, ILIA I
Art Unit1644
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.